Cadila Healthcare Q3 Results: Firm posts 5% decline in profit at Rs 500 crConsolidated total revenue from operations stood at Rs 3,655 crore during the quarter under review as compared to Rs 3,633 crore in the yea...
Covid: 11.7% rise in 2nd dose coverage till November 30 during Har Ghar Dastak vaccination driveLaunched on November 3, the 'Har Ghar Dastak' campaign aims at awareness, mobilisation and vaccination of all eligible beneficiaries throug...
Cadila's Covid vax to be introduced in 7 states firstThe Indian government will initially introduce Cadila Healthcare's Covid-19 vaccine ZyCoV-D in seven states, including Maharashtra and West...
Zydus Cadila's Covid vaccine to be administered only to adults as of now: SourcesZydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be a...
NTAGI to soon come out with guidelines on vaccinating kidsZyCoV-D is the first DNA plasmid vaccine in the world , developed indigenously by the company against the Covid-19 virus.
Zydus Cadila to get clarity on ZyCoV-D Covid vaccine pricing in 1-2 weeks: MD Sharvil PatelOn Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...
Right pricing to hold the key for Zydus Cadila's vaccine launchZydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. A...
India first to develop DNA vaccine, can be administered to 12 and above: PM Narendra Modi"India, which lives on Sewa Paramo Dharma (service is the main duty), is engaged in vaccination development and manufacturing despite limit...
Zydus Cadila's vaccine for kids above 12 to come up for approval this weekThe drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The r...
Needle-free injectors: After anaesthesia, this could be the next great breakthroughA number of companies, including one called PharmaJet and another called BioJect, have developed needle-free injectors.